rs587781564
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PM4PP3PP5_Moderate
The NM_000546.6(TP53):c.838_848delAGAGACCGGCGinsCA(p.Arg280_Arg283delinsHis) variant causes a missense, conservative inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. R280R) has been classified as Likely benign.
Frequency
Consequence
NM_000546.6 missense, conservative_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- breast cancerInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- Li-Fraumeni syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
- Li-Fraumeni syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
- adrenocortical carcinoma, hereditaryInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- bone marrow failure syndrome 5Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- colorectal cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- choroid plexus carcinomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
​The c.838_848del11insCA variant, located in coding exon 7 of the TP53 gene, results from the deletion of 11 nucleotides at position 838 to 848 and the insertion of 2 nucleotides (C and A) in the deleted region. The result of this deletion and insertion is the loss of four amino acids at codon 280 to 283 (arginine, aspartic acid, arginine, and arginine) and the insertion of one different amino acid, histidine, at the new codon 280. This is not a frameshift mutation, but the result of this variant is predicted to be a protein that is three amino acids shorter than the wild-type.Alterations in one of the deleted codons, codon 282, are among the most common TP53 mutations found in both sporadic tumors and in the germline (Malkin, D. Genes Cancer. 2011 Apr;2(4):475-84).In addition, this variant is located in a DNA-binding domain, and mutations in this region are known to cause a more highly penetrate cancer phenotype than mutations in other regions (Silva, AG. Orphanet J Rare Dis. 2012 Dec 21;7:101; Birch, JM. Oncogene.1998 Sep 3;17(9):1061-8). This variant was not reported in population-based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP) and 1000 Genomes Project. To date, this alteration has been detected with an allele frequency of approximately 0.01% (greater than 10700 alleles tested) in our clinical cohort (includes this individual). There are no available functional studies to aid in predicting the impact of this variant on the TP53 protein, but based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at